{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:12:25Z","timestamp":1791234745219,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":805,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1111\/ced.12000","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T12:37:38Z","timestamp":1371559058000},"page":"538-544","source":"Crossref","is-referenced-by-count":13,"title":["Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis"],"prefix":"10.1093","volume":"38","author":[{"given":"I. J.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kasprowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Tharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"10.1111\/ced.12000-BIB1|cit1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0733-8635(05)70308-9","article-title":"Mastocytosis","volume":"19","author":"Tharp","year":"2001","journal-title":"Dermatol Clin"},{"key":"10.1111\/ced.12000-BIB2|cit2","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1371\/journal.pone.0001906","article-title":"Phenotypic and genotypic characteristics of mastocytosis according to the age of onset","volume":"3","author":"Lanternier","year":"2008","journal-title":"PLoS One"},{"key":"10.1111\/ced.12000-BIB3|cit3","first-page":"965","article-title":"The c- KIT receptor, stem cell factor, and mast cells. What each is teaching us about the others","volume":"142","author":"Galli","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1111\/ced.12000-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ced.12000-BIB5|cit5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ced.12000-BIB6|cit6","first-page":"5956","article-title":"Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers","volume":"286","author":"Roberts","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1111\/ced.12000-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20050807","article-title":"Mastocytosis in mice expressing human KIT receptor with the activating Asp816Val mutation","volume":"202","author":"Zappulla","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/ced.12000-BIB8|cit8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.exphem.2005.11.015","article-title":"Establishment of a murine model of aggressive systemic mastocytosis\/mast cell leukemia","volume":"34","author":"Demehri","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1111\/ced.12000-BIB9|cit9","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1182\/blood-2008-04-155085","article-title":"Pak1 regulates multiple c-KIT mediated Ras-MAPK gain-in-function phenotypes in Nf1+\/- mast cells","volume":"112","author":"McDaniel","year":"2008","journal-title":"Blood"},{"key":"10.1111\/ced.12000-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood-2007-06-097253","article-title":"RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia","volume":"111","author":"Jeffrey","year":"2008","journal-title":"Blood"},{"key":"10.1111\/ced.12000-BIB11|cit11","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.4049\/jimmunol.180.7.4586","article-title":"Activation and function of the TORC1 pathway in mast cells","volume":"180","author":"Kim","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/ced.12000-BIB12|cit12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-213X-8-42","article-title":"The small molecule Mek1\/2 inhibitor U0126 disrupts the chordamesoderm to notochord transition in zebrafish","volume":"8","author":"Hawkins","year":"2008","journal-title":"BMC Dev Biol"},{"key":"10.1111\/ced.12000-BIB13|cit13","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1074\/jbc.M110.182642","article-title":"Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells","volume":"286","author":"Chaix","year":"2011","journal-title":"Biol Chem"},{"key":"10.1111\/ced.12000-BIB14|cit14","first-page":"218","article-title":"Prevention of UVB-induced skin inflammation, genotoxicity, and photocarcinogenesis in mice by WHI-P131, a dual-function inhibitor of Janus kinase 3 and EGF receptor kinase","volume":"60","author":"Uckun","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/ced.12000-BIB15|cit15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/ced.12000-BIB16|cit16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/0264-6021:3440427","article-title":"Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation","volume":"344","author":"Nav\u00e9","year":"1999","journal-title":"Biochem J"},{"key":"10.1111\/ced.12000-BIB17|cit17","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1074\/jbc.275.10.7416","article-title":"FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions","volume":"275","author":"Peterson","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/ced.12000-BIB18|cit18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.1111\/ced.12000-BIB19|cit19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1111\/ced.12000-BIB20|cit20","first-page":"1115","article-title":"Juxtamembrane mutant V560GKit is more sensitive to imatinib (STI571) compared with wild-type c-KIT whereas the kinase domain mutant D816VKit is resistant","volume":"1","author":"Frost","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/ced.12000-BIB21|cit21","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","article-title":"Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens","volume":"180","author":"Mayerhofer","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/ced.12000-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1182\/blood-2005-06-2433","article-title":"Rapamycin inhibits growth and survival of D816V-mutated c-KIT mast cells","volume":"108","author":"Gabillot-Carr\u00e9","year":"2006","journal-title":"Blood"},{"key":"10.1111\/ced.12000-BIB23|cit23","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1074\/jbc.M109.078592","article-title":"Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in a c-KIT-dependent gastrointestinal stromal tumor cell line","volume":"285","author":"Gordon","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1111\/ced.12000-BIB24|cit24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10428190903486220","article-title":"Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis","volume":"51","author":"Parikh","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/ced.12000-BIB25|cit25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12000","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12000\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:37:28Z","timestamp":1676385448000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/38\/5\/538\/6623081"}},"subtitle":["Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis"],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12000","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,18]]}}}